Insight

Opinion

Benjamin Diamond: Our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research

Photo of Benjamin Diamond from X

Apr 27, 2024, 07:10

Benjamin Diamond: Our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research

Benjamin Diamond, Assistant Professor of the Myeloma Institute at the Sylvester Comprehensive Cancer Center, shared on X/Twitter:

“We’re happy to share our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research. We think genomic contextualization is critical to understanding SMM interventional studies given the limitations of current clinical risk scores.

Big thanks to all who made this possible! Diko Kazandjian, C. Ola Landgren, Francesco Maura, Irene Ghobrial, Romanos SP, Sylvester Comprehensive Cancer Center, Patrick Blaney, Saad Z. Usmani, Faith E Davies, Gareth Morgan, Gad Getz Laboratory, and Multiple Myeloma RF.

Here’s a link to our previous medRxiv tweetorial if you want the key points.”

Source: Ben Diamond/X

Benjamin Diamond C. Ola Landgren cancer Clinical Cancer Research Diko Kazandjian Faith E Davies Francesco Maura Gad Getz Laboratory Gareth Morgan high-risk smouldering myeloma Irene Ghobrial Multiple Myeloma RF Myeloma Myeloma Institute OncoDaily Oncology Patrick Blaney Romanos SP Saad Z. Usmani Sylvester Comprehensive Cancer Center

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage